Allergan Plc Valuation

Allergan Plc Investor Information

About 98.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.07. Some equities with similar Price to Book (P/B) outperform the market in the long run. Allergan Plc recorded a loss per share of 27.98. The entity had 2:1 split on the 30th of October 1997. Based on the measurements of operating efficiency obtained from Allergan Plc's historical financial statements, Allergan Plc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.

Allergan Plc Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Allergan Plc has an asset utilization ratio of 11.67 percent. This suggests that the Company is making $0.12 for each dollar of assets. An increasing asset utilization means that Allergan Plc is more efficient with each dollar of assets it utilizes for everyday operations.

Allergan Plc Ownership Allocation

Allergan Plc holds a total of 328.1 Million outstanding shares. The majority of Allergan Plc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Allergan Plc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Allergan Plc. Please pay attention to any change in the institutional holdings of Allergan Plc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Allergan Plc Profitability Analysis

The company reported the last year's revenue of 15.82 B. Reported Net Loss for the year was (9.25 B) with profit before taxes, overhead, and interest of 13.65 B.

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

If you are still planning to invest in Allergan Plc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Allergan Plc's history and understand the potential risks before investing.